Cape Verde vs Trinidad and Tobago: Previously treated cases tested for RR-/MDR-TB
Cape Verde
20.0%
in 2024
Trinidad and Tobago
27.0%
in 2024
Cape Verde rank
165th
Trinidad and Tobago rank
163rd
Previously treated cases tested for RR-/MDR-TB over time
- Cape Verde
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 27.0% against 20.0% in Cape Verde, a difference of 7.0%.
That makes Trinidad and Tobago's figure about 1.4 times Cape Verde's.
The two have swapped places 2 times across 14 shared years of data; in 2008 it was Trinidad and Tobago ahead.
Cape Verde ranks 165th and Trinidad and Tobago ranks 163rd of 180 countries.
Across the 3 decades both report, Cape Verde averaged higher in 1 and Trinidad and Tobago in 2.
Head to head by decade
| Decade | Cape Verde | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.6% | 3.2% | 1.6% | Trinidad and Tobago |
| 2010s | 22.3% | 47.0% | 24.7% | Trinidad and Tobago |
| 2020s | 59.6% | 32.0% | 27.6% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cape Verde or Trinidad and Tobago?
- Trinidad and Tobago, at 27.0% against 20.0% in Cape Verde as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cape Verde and Trinidad and Tobago?
- 7.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Cape Verde and Trinidad and Tobago?
- 14 years are reported by both, from 2008 to 2024.
- How do Cape Verde and Trinidad and Tobago rank globally for previously treated cases tested for rr-/mdr-tb?
- Cape Verde ranks 165th and Trinidad and Tobago ranks 163rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.